Top Page
Silex Systems Limited
(Sydney:SLX)
Silex Systems Limited (SLX) vs. iShares MSCI Australia ETF (EWA)
Silex Systems Limited Business Overview & Revenue Model
Silex Systems Limited Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.21M | 6.79M | 6.11M | 6.84M | 4.22M | 1.92M |
| Gross Profit | -3.42M | 6.79M | -5.09M | -1.98M | -2.86M | -4.42M |
| EBITDA | -3.89M | -41.97M | -22.27M | -5.53M | -9.00M | -6.61M |
| Net Income | -30.63M | -42.56M | -22.73M | -17.36M | -9.46M | -6.93M |
Balance Sheet | ||||||
| Total Assets | 122.80M | 98.96M | 141.56M | 152.20M | 54.12M | 24.04M |
| Cash, Cash Equivalents and Short-Term Investments | 94.59M | 81.96M | 117.00M | 140.74M | 46.53M | 19.90M |
| Total Debt | 1.03M | 910.20K | 1.18M | 772.14K | 982.50K | 38.40K |
| Total Liabilities | 8.12M | 8.01M | 9.62M | 3.51M | 3.57M | 1.97M |
| Stockholders Equity | 114.68M | 90.95M | 131.94M | 148.69M | 50.55M | 22.07M |
Cash Flow | ||||||
| Free Cash Flow | 4.73M | 2.86M | 5.85M | -2.43M | 287.28K | -4.96M |
| Operating Cash Flow | 4.95M | 3.02M | 6.14M | -2.34M | 412.64K | -4.78M |
| Investing Cash Flow | 7.75M | -2.61M | 7.56M | -114.40M | -40.06M | 9.79M |
| Financing Cash Flow | 2.47M | 403.06K | 2.34M | 114.55M | 38.20M | -199.34K |
Silex Systems Limited Technical Analysis
Silex Systems Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | AU$1.30B | 17.51 | 65.33% | 9.53% | 25.67% | 744.90% | |
64 Neutral | AU$566.19M | 31.56 | 8.20% | ― | 1.06% | -30.96% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | AU$965.95M | -23.62 | -50.48% | ― | 333.23% | 10.83% | |
53 Neutral | $2.61B | ― | -37.20% | ― | 5.81% | -86.09% | |
51 Neutral | AU$32.34M | -0.55 | -121.41% | ― | ― | -1034.67% | |
44 Neutral | AU$773.06M | -82.50 | -3.19% | ― | 0.40% | -280.65% |
Silex Systems Limited Corporate Events
Silex Systems Limited has announced the quotation of 386,400 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 4, 2025. This move involves the issuance, transfer, or reclassification of securities due to options being exercised or convertible securities being converted. The announcement signifies an expansion in the company’s securities, potentially impacting its market presence and offering implications for stakeholders regarding the company’s growth and financial strategies.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$10.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced that its SILEX laser-based uranium enrichment technology, licensed to Global Laser Enrichment (GLE), has achieved Technology Readiness Level 6 (TRL-6) following a successful large-scale demonstration. This milestone is a significant step towards commercial deployment, with plans to establish a manufacturing base in the US and develop the Paducah Laser Enrichment Facility in Kentucky. The facility aims to enhance US domestic uranium enrichment capacity and could play a crucial role in nuclear fuel production for current and future reactors, subject to market and regulatory conditions.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited has announced a change in the director’s interest, with Michael Goldsworthy acquiring 208,600 Performance Rights. These rights were issued as part of short-term and long-term incentives for FY2026, following shareholder approval at the 2025 AGM. This move reflects the company’s strategic efforts to align executive incentives with its long-term goals, potentially impacting its operational focus and stakeholder interests.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced the results of its 2025 Annual General Meeting, where all resolutions were passed by poll. The resolutions included the re-election of directors, approval of incentive plans, and renewal of takeover provisions, indicating strong shareholder support for the company’s strategic direction. This outcome is likely to reinforce Silex’s position in the market and provide confidence to its stakeholders regarding its governance and future plans.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced its ongoing development efforts in uranium enrichment technology and its exploration of new commercial applications, including quantum silicon production and medical isotope separation. The company’s projects face various risks and uncertainties, including market conditions, regulatory changes, and geopolitical factors, which could impact their commercial viability and success.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited has made significant progress in advancing its SILEX uranium enrichment technology, with key milestones achieved in its commercialization efforts, including technology demonstration and regulatory advancements. The company is well-positioned to benefit from the global nuclear industry’s expansion and is actively pursuing opportunities in the US nuclear fuel supply sector. Additionally, Silex is developing its Quantum Silicon Production Project, engaging with potential customers in the quantum computing sector. The company has strengthened its financial position through a successful equity raise, ensuring funding through FY2028.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Global Laser Enrichment (GLE), the exclusive licensee of Silex’s uranium enrichment technology, has successfully completed large-scale enrichment demonstration testing in North Carolina, marking a significant milestone towards commercial deployment. This advancement positions GLE as the only company operating large-scale, third-generation laser-based enrichment technology, with plans to further develop a domestic manufacturing base in the US. The project’s success could significantly impact the nuclear fuel production industry, with potential contributions to both current and future nuclear reactor fleets.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited has announced its 2025 Annual General Meeting (AGM) scheduled for October 17, 2025, which will be conducted as a hybrid event allowing both in-person and online participation. The AGM will cover several key business items, including the adoption of the 2025 Remuneration Report, re-election of a director, and approval of incentive plans for the CEO, which could impact the company’s governance and strategic direction.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced the quotation of 4,978,649 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of September 5, 2025. This development is part of previously announced transactions and could potentially impact the company’s market presence and liquidity, offering stakeholders an opportunity to engage with the company’s growth trajectory.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited has announced the issuance of 150,600 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX). This move is part of the company’s strategy to enhance its market presence and potentially increase its capital base, which could have implications for its operations and stakeholders.
The most recent analyst rating on (AU:SLX) stock is a Buy with a A$6.64 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced the successful completion of its Share Purchase Plan (SPP), raising approximately $19.4 million, surpassing the initial target of $15 million. The funds will support the commercialization of the SILEX uranium enrichment technology in the US and other isotope enrichment opportunities, enhancing the company’s market positioning and operational capabilities.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced a change in the director’s interest, with Michael Goldsworthy acquiring 45,000 fully paid ordinary shares through the vesting of Performance Rights under the company’s Employee Incentive Plan. This change reflects the company’s commitment to aligning executive interests with performance-based goals, potentially impacting the company’s operational focus and stakeholder confidence.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced the cessation of certain securities, specifically 239,203 performance rights and 50,000 options, due to their expiry without exercise or conversion. This cessation reflects a routine adjustment in the company’s issued capital, which may impact stakeholders’ perceptions of the company’s financial strategy and market positioning.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced the quotation of 318,997 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective August 29, 2025. This move is part of the company’s strategy to expand its capital base and enhance its market presence, potentially impacting its financial operations and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited is an Australian technology company specializing in the commercialization of its SILEX laser enrichment technology, primarily for uranium enrichment, quantum silicon production, and medical isotope separation. In its latest earnings report, Silex highlighted significant progress in its uranium enrichment technology, with its partner Global Laser Enrichment LLC (GLE) advancing the TRL-6 pilot demonstration program. Key developments include GLE’s acquisition of land for the Paducah Laser Enrichment Facility and participation in the US Department of Energy’s LEU Enrichment Acquisition program. The company also raised $130 million to support its commercialization efforts. Silex’s management remains optimistic about the future, focusing on the completion of the TRL-6 program and potential commercial operations by 2030, amid favorable market conditions and government support.
Silex Systems Limited’s 2025 Annual Report highlights the ongoing development and commercialization efforts of its SILEX technology, particularly in uranium enrichment in collaboration with Global Laser Enrichment LLC. The company is also advancing projects in quantum silicon production and medical isotope separation, though these initiatives face various risks and uncertainties. The report underscores the speculative nature of these technologies’ commercial futures, influenced by market conditions, regulatory changes, and geopolitical factors.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited reported a significant financial downturn for the fiscal year ending June 30, 2025, with a notable decrease in cash and cash equivalents by 28.8% and a substantial increase in net loss by 87.2%. Despite a rise in other income, the overall financial performance reflects challenges that may impact the company’s market position and stakeholder confidence.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited has announced the release of 116,298 ordinary shares from voluntary escrow, effective on September 4, 2025. This move is in line with ASX Listing Rule 3.10A and may impact the company’s share liquidity and market perception, potentially influencing investor sentiment and stakeholder interests.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited has announced a Share Purchase Plan (SPP) aiming to raise up to $15 million, with the potential to increase to $20 million at the discretion of the board. This initiative is designed to offer continuously quoted securities to eligible shareholders in Australia and New Zealand, excluding those in the United States, without the need for a prospectus. The SPP allows shareholders to purchase shares potentially at a lower price than the market rate, although they are advised to seek independent financial advice due to the irrevocable nature of the application.
The most recent analyst rating on (AU:SLX) stock is a Buy with a A$6.21 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
JPMorgan Chase & Co. and its affiliates have ceased to be substantial holders in Silex Systems Limited as of August 12, 2025. This change in holdings could impact the company’s shareholder structure and influence its market perception, as JPMorgan’s involvement was significant in terms of voting securities.
The most recent analyst rating on (AU:SLX) stock is a Buy with a A$6.21 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited has announced the quotation of 33,333,334 fully paid ordinary securities on the Australian Securities Exchange (ASX), with the issue date set for August 14, 2025. This move is part of previously announced transactions and could potentially enhance the company’s financial flexibility and market presence.
The most recent analyst rating on (AU:SLX) stock is a Buy with a A$6.21 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.